DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical and Healthcare Industry in China – Forecast and Analysis 2021” report has been added to ResearchAndMarkets.com’s offering.
The COVID-19 pandemic has had quite an impact on the Chinese pharmaceutical and healthcare industry, through industry analysts expect a speedy recovery back to normal levels of demand.
The Chinese pharmaceutical and healthcare industry is one of the largest markets in the world, and it is well on its way to becoming a leading global hub for drug innovation and drug development. Even as the COVID-19 crisis rages on, there is an increasing international investment in the Chinese pharma and healthcare sectors.
China’s healthcare and pharmaceutical landscape is looking at promising new healthcare reforms in the coming years as the government looks to provide quality healthcare to its population’s increasing demand. On March 5, 2021, the government announced institutional healthcare reforms in line with China’s 14th Five Year Plan (2021-2025).
The government has also highlighted a detailed roadmap for enhancing the overall quality of healthcare in the country while also expanding the necessary services in this sector. With generic drugs being the mainstay of the country’s population, generics accounted for nearly 65% of the overall pharmaceutical industry in 2020.
While growth in the pharmaceutical industry is unlikely to return to pre-pandemic highs, China will continue to remain one of the biggest markets for drugmakers worldwide.
The report covers the following data:
Key Topics Covered:
A. Executive Summary
B. Industry Definition
C. Brief View of the APAC Pharmaceutical & Healthcare Sector
D. Pharmaceutical & Healthcare Industry in China
D.1 Impact of COVID-19 on the Industry
D.2 Pharmaceutical Sector Analysis
D.3 Healthcare Sector Analysis
D.4 Market for Prescription Drugs
D.5 Market for Patented Drugs
D.6 Market for OTC Medicines
D.7 Market for Generic Drugs
D.8 Medical Research & Clinical Trials in China
E. Pharmaceutical & Healthcare Industry in China: SWOT Analysis
E.1 Strengths to Build Upon
E.2 Weaknesses to Overcome
E.3 Opportunities to Exploit
E.4 Threats to Overcome
F. China Pharmaceutical Industry: Porter’s Five Forces Strategy Analysis
F.1 Overview
F.2 Bargaining Power of Buyers
F.3 Bargaining Power of Suppliers
F.4 Competitive Rivalry in the Industry
F.5 Threat of New Entrants
F.6 Threat of Substitutes
G. Chronic Medical Conditions in China
G.1 Overview
G.2 Cancer
G.3 Chronic Obstructive Pulmonary Disease
G.4 Diabetes
H. Regulatory Framework of the Industry
H.1 Overview
H.2 China’s 14th Five-Year Plan for Healthcare Reforms
H.3 Regulations Governing OTC Drugs
H.4 Regulations Governing Biosimilars
H.5 Challenges with Intellectual Property Rights
H.6 Challenges with Counterfeit Medications
H.7 Pricing & Reimbursement Regime
H.8 Regulations Governing Marketing of Pharmaceuticals
I. Import/Export of Pharmaceuticals in China
J. Competition in the Industry
J.1 Competitive Landscape
J.2 Competition in Generic Drugs
J.3 Competition in the Pharmacy Sector
J.4 Competition in Drug Distribution
K. Forecast: Pharmaceutical & Healthcare Industry in China
K.1 Outlook of the Chinese Pharmaceutical Industry
K.2 Outlook of the Chinese Healthcare Industry
K.3 Outlook for Prescription Drugs Sector
K.4 Outlook for Patented Drugs Market
K.5 Outlook for OTC Medicine Market
K.6 Outlook for the Generic Drugs Market
L. Major Domestic & Multinational Players
For more information about this report visit https://www.researchandmarkets.com/r/cavx5l
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Joint Effort Aims to Accelerate Growth and Expansion of Thai Companies in Singapore SINGAPORE -…
BEIJING, CHINA - Media OutReach Newswire - 18 September 2024 - At the recent 2024…
BEIJING, CHINA - Media OutReach Newswire - 18 September 2024 - On September 13, the…
BEIJING, CHINA - Media OutReach Newswire - 18 September 2024 - On September 13, at…
BEIJING, CHINA - Media OutReach Newswire - 18 September 2024 - On September 12, the…
BEIJING, CHINA - Media OutReach Newswire - 18 September 2024 - The 2024 China International…